SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-106686
Filing Date
2013-03-14
Accepted
2013-03-14 12:21:04
Documents
1
Period of Report
2013-03-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d502379d8k.htm 8-K 15285
  Complete submission text file 0001193125-13-106686.txt   16656
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52062 | Film No.: 13689705
SIC: 2834 Pharmaceutical Preparations